Bath & Body Works, Inc. $BBWI Shares Sold by Diamond Hill Capital Management Inc.

Diamond Hill Capital Management Inc. reduced its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 34.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 241,609 shares of the company’s stock after selling 127,843 shares during the period. Diamond Hill Capital Management Inc.’s holdings in Bath & Body Works were worth $4,852,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Retirement Systems of Alabama lifted its position in shares of Bath & Body Works by 40.6% during the 3rd quarter. Retirement Systems of Alabama now owns 772,324 shares of the company’s stock worth $19,895,000 after purchasing an additional 223,089 shares during the last quarter. Allianz Asset Management GmbH lifted its position in shares of Bath & Body Works by 58.8% during the 3rd quarter. Allianz Asset Management GmbH now owns 263,628 shares of the company’s stock worth $6,791,000 after purchasing an additional 97,640 shares during the last quarter. Access Investment Management LLC purchased a new stake in shares of Bath & Body Works during the 3rd quarter worth $3,506,000. Great Lakes Advisors LLC lifted its position in shares of Bath & Body Works by 113.2% during the 3rd quarter. Great Lakes Advisors LLC now owns 206,381 shares of the company’s stock worth $5,316,000 after purchasing an additional 109,595 shares during the last quarter. Finally, SG Americas Securities LLC lifted its position in shares of Bath & Body Works by 725.3% during the 4th quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock worth $9,364,000 after purchasing an additional 409,831 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

Shares of BBWI opened at $17.74 on Friday. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $33.96. The stock has a market cap of $3.57 billion, a PE ratio of 5.63, a price-to-earnings-growth ratio of 1.72 and a beta of 1.43. The firm has a fifty day moving average price of $18.72 and a 200 day moving average price of $20.37.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The business had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.59 billion. During the same period in the prior year, the company earned $2.09 earnings per share. The business’s revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities analysts expect that Bath & Body Works, Inc. will post 2.61 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date of this dividend is Friday, June 5th. Bath & Body Works’s dividend payout ratio is presently 25.40%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on BBWI. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Tuesday, March 3rd. Barclays boosted their price target on shares of Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, March 2nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research report on Monday, April 20th. Citigroup cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and boosted their price target for the company from $21.00 to $25.00 in a research report on Tuesday, February 17th. Finally, Piper Sandler initiated coverage on shares of Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. Three analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $21.21.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.